Statistics for Olaparib Plus Abiraterone Versus Placebo Plus Abiraterone in Metastatic Castration-Resistant Prostate Cancer (propel): Final Prespecified Overall Survival Results of a Randomised, Double-Blind, Phase 3 Trial
Total visits
| views | |
|---|---|
| Olaparib Plus Abiraterone Versus Placebo Plus Abiraterone in Metastatic Castration-Resistant Prostate Cancer (propel): Final Prespecified Overall Survival Results of a Randomised, Double-Blind, Phase 3 Trial | 0 |
Total visits per month
| views | |
|---|---|
| September 2025 | 0 |
| October 2025 | 0 |
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 0 |
| March 2026 | 0 |
File Visits
| views | |
|---|---|
| 4932.pdf | 9 |